This work investigates the systemic relationship between economic deprivation and the prevalence of infectious and chronic diseases in developing nations. Philip Stevens, a researcher specializing in health policy and international development, examines how lack of infrastructure, limited access to medical innovation, and trade barriers exacerbate health crises. The book argues that economic growth and the liberalization of pharmaceutical markets are essential components in reducing the global burden of disease among the world's poorest populations.

Experts in development economics often cite this text for its focus on market-based solutions to public health challenges. Readers frequently note the academic density of the prose and the author's reliance on economic data to support his policy recommendations.